Philippe Sauvage, CFO of Nuvation Bio Inc. ($NUVB), made two open market purchases of company shares worth $13,216 over the past year, with the latest on June 17, 2025. These buys rank 4,114th among nearly 5,000 insiders, well below the average of $1.5 million per buyer across 3.3 transactions. He reported no open market sales in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Nuvation Bio Inc. | $NUVB | Sauvage Philippe | Chief Financial Officer | A | Stock Option (Right to Buy) | 748130 | $0.00 | 748,130.0000 | 342,833,433 | 9999.99% | 0.22% |
| June 16, 2025 | Nuvation Bio Inc. | $NUVB | Sauvage Philippe | Chief Financial Officer | P | Class A Common Stock | 3300 | $1.84 | 5,902.0000 | 337,678,855 | 126.83% | 0.00% |
| June 17, 2025 | Nuvation Bio Inc. | $NUVB | Sauvage Philippe | Chief Financial Officer | P | Class A Common Stock | 4000 | $1.79 | 9,902.0000 | 337,678,855 | 67.77% | 0.00% |
| Feb. 28, 2025 | Nuvation Bio Inc. | $NUVB | Sauvage Philippe | Chief Financial Officer | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 7, 2024 | Nuvation Bio Inc. | $NUVB | Sauvage Philippe | Chief Financial Officer | A | Stock Option (Right to Buy) | 750000 | $0.00 | 750,000.0000 | 0 | 9999.99% | 0.00% |